Exploring procedure duration and risk for serious adverse events during congenital cardiac catheterization
- PMID: 36643781
- PMCID: PMC9835933
- DOI: 10.1136/bmjsit-2022-000142
Exploring procedure duration and risk for serious adverse events during congenital cardiac catheterization
Abstract
Objectives: While procedure length is considered an important metric for cardiothoracic surgical procedures, the relationship between procedure length and adverse events (AEs) in congenital cardiac catheterizations has little published data available. Furthermore, most existing congenital cardiac catheterization risk prediction models are built on logistic regression models. This study aimed to characterize the relationship between case length and AE occurrence in congenital cardiac catheterization while adjusting for known risk factors and to investigate the potential role of non-linear analysis in risk modeling.
Design: Age, case type, and procedure duration were evaluated for relationships with the primary outcome using logistic regression. Non-linearity of the associations with continuous risk factors was assessed using restricted cubic spline transformations.
Setting and participants: All diagnostic and interventional congenital cardiac catheterization cases performed at Boston Children's Hospital between January 1, 2014 and October 31, 2019 were analyzed.
Main outcome measure: The primary outcome was defined as the occurrence of any clinically significant (level 3/4/5) AE.
Results: A total of 7011 catheterization cases met inclusion criteria, with interventional procedures accounting for 68% of cases. Median case duration was 97 min. A multivariable model including age, procedure type, and case duration showed a significant relationship between case duration and AE occurrence (OR 1.07 per 10 min increase, 95% CI 1.06 to 1.09, p<0.001).
Conclusions: This study demonstrated the importance of procedure duration as a potential frontier for procedure risk management. Better understanding of the role of procedure duration in cardiac catheterizations may provide opportunities for quality improvement in patient safety and resource planning.
Keywords: Cardiac Devices; Methodology; Outcomes Research; Patient Outcome Assessment.
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures

References
-
- Jayaram N, Spertus JA, Kennedy KF, et al. . Modeling major adverse outcomes of pediatric and adult patients with congenital heart disease undergoing cardiac catheterization: observations from the NCDR impact registry (national cardiovascular data registry improving pediatric and adult congenital treatment). Circulation 2017;136:2009–19. 10.1161/CIRCULATIONAHA.117.027714 - DOI - PMC - PubMed
-
- Bergersen L, Giroud JM, Jacobs JP, et al. . Report from the International Society for nomenclature of paediatric and congenital heart disease: cardiovascular catheterisation for congenital and paediatric cardiac disease (Part 2 – Nomenclature of complications associated with interventional cardiology). Cardiol Young 2011;21:260–5. 10.1017/S1047951110001861 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous